Profil Financier
Zhong Huijuan occupe actuellement le rang #149 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $18.4 B (+$398 sur 24h).
Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.
Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong.
Their daughter, Sun Yuan, is Hansoh's executive director.
Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.
Hansoh has licensed products including cancer treatments to global pharmaceutical giants such as Roche and Glenmark in billion-dollar deals, as the firm expands internationally.